{"id":"https://openalex.org/W7127048769","doi":"https://doi.org/10.1016/j.msard.2026.107044","title":"No evidence of disease activity after fingolimod treatment: A three-year real-world comparison of pre- and post-treatment outcomes in multiple sclerosis","display_name":"No evidence of disease activity after fingolimod treatment: A three-year real-world comparison of pre- and post-treatment outcomes in multiple sclerosis","alternate_titles":[],"publication_year":2026,"publication_date":"2026-02-02","ids":{"openalex":"https://openalex.org/W7127048769","doi":"https://doi.org/10.1016/j.msard.2026.107044","pmid":"https://pubmed.ncbi.nlm.nih.gov/41653645"},"language":"en","primary_location":{"id":"doi:10.1016/j.msard.2026.107044","doi":"https://doi.org/10.1016/j.msard.2026.107044","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.msard.2026.107044","pdf_url":null,"source":{"id":"https://openalex.org/S2764622253","display_name":"Multiple Sclerosis and Related Disorders","issn_l":"2211-0348","issn":["2211-0348","2211-0356"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis and Related Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7127048769"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5093027486","display_name":"Ulvi Samadzade","orcid":"https://orcid.org/0000-0003-1481-151X","observed_orcids":["https://orcid.org/0000-0003-1481-151X"]},"institutions":[{"id":"https://openalex.org/I15059493","display_name":"\u0130zmir University of Economics","ror":"https://ror.org/04hjr4202","country_code":"TR","type":"education","lineage":["https://openalex.org/I15059493"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Ulvi Samadzade","raw_affiliation_strings":["Izmir University of Economics, Neurology Clinic, Sakarya Street, No:156, Bal\u00e7ova, \u0130zmir, TR 35330, Turkey. Electronic address: ulvisemedzade308@gmail.com"],"raw_orcid":"https://orcid.org/0000-0003-1481-151X","affiliations":[{"raw_affiliation_string":"Izmir University of Economics, Neurology Clinic, Sakarya Street, No:156, Bal\u00e7ova, \u0130zmir, TR 35330, Turkey. Electronic address: ulvisemedzade308@gmail.com","institution_ids":["https://openalex.org/I15059493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5117063374","display_name":"Said Alizada","orcid":"https://orcid.org/0009-0004-7126-1475","observed_orcids":["https://orcid.org/0009-0004-7126-1475"]},"institutions":[{"id":"https://openalex.org/I193615760","display_name":"Dokuz Eyl\u00fcl University","ror":"https://ror.org/00dbd8b73","country_code":"TR","type":"education","lineage":["https://openalex.org/I193615760"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Said Alizada","raw_affiliation_strings":["Dokuz Eyl\u00fcl University, Department of Neurology, \u0130nciralt\u0131 Mahallesi, Mithatpa\u015fa Cad. No:1606, 9 Eyl\u00fcl Hospital, Neurology, Alsancak, \u0130zmir, TR 35210, Turkey. Electronic address: said.alizada@outlook.com"],"raw_orcid":"https://orcid.org/0009-0004-7126-1475","affiliations":[{"raw_affiliation_string":"Dokuz Eyl\u00fcl University, Department of Neurology, \u0130nciralt\u0131 Mahallesi, Mithatpa\u015fa Cad. No:1606, 9 Eyl\u00fcl Hospital, Neurology, Alsancak, \u0130zmir, TR 35210, Turkey. Electronic address: said.alizada@outlook.com","institution_ids":["https://openalex.org/I193615760"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124711417","display_name":"Can Caliskan","orcid":"https://orcid.org/0000-0001-8168-3568","observed_orcids":["https://orcid.org/0000-0001-8168-3568"]},"institutions":[{"id":"https://openalex.org/I15059493","display_name":"\u0130zmir University of Economics","ror":"https://ror.org/04hjr4202","country_code":"TR","type":"education","lineage":["https://openalex.org/I15059493"]},{"id":"https://openalex.org/I193615760","display_name":"Dokuz Eyl\u00fcl University","ror":"https://ror.org/00dbd8b73","country_code":"TR","type":"education","lineage":["https://openalex.org/I193615760"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Can Caliskan","raw_affiliation_strings":["Department of Internal Medicine Nursing, Institute of Health Sciences, Dokuz Eylul, University, Izmir, Turkey; Center for Treatment and Research of Neuroimmunological Disorders, Izmir University of Economics, Medical Point Hospital, Izmir, Turkey. Electronic address: canxcaliskan@gmail.com"],"raw_orcid":"https://orcid.org/0000-0001-8168-3568","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine Nursing, Institute of Health Sciences, Dokuz Eylul, University, Izmir, Turkey; Center for Treatment and Research of Neuroimmunological Disorders, Izmir University of Economics, Medical Point Hospital, Izmir, Turkey. Electronic address: canxcaliskan@gmail.com","institution_ids":["https://openalex.org/I15059493","https://openalex.org/I193615760"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124734681","display_name":"Orkhan Mammadov","orcid":"https://orcid.org/0009-0002-0769-4853","observed_orcids":["https://orcid.org/0009-0002-0769-4853"]},"institutions":[{"id":"https://openalex.org/I193615760","display_name":"Dokuz Eyl\u00fcl University","ror":"https://ror.org/00dbd8b73","country_code":"TR","type":"education","lineage":["https://openalex.org/I193615760"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Orkhan Mammadov","raw_affiliation_strings":["Dokuz Eyl\u00fcl University, Department of Neurology, \u0130nciralt\u0131 Mahallesi, Mithatpa\u015fa Cad. No:1606, 9 Eyl\u00fcl Hospital, Neurology, Alsancak, \u0130zmir, TR 35210, Turkey. Electronic address: mammadovorkhan7@hotmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dokuz Eyl\u00fcl University, Department of Neurology, \u0130nciralt\u0131 Mahallesi, Mithatpa\u015fa Cad. No:1606, 9 Eyl\u00fcl Hospital, Neurology, Alsancak, \u0130zmir, TR 35210, Turkey. Electronic address: mammadovorkhan7@hotmail.com","institution_ids":["https://openalex.org/I193615760"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090065082","display_name":"Serkan \u00d6zakba\u015f","orcid":"https://orcid.org/0000-0003-2140-4103","observed_orcids":["https://orcid.org/0000-0003-2140-4103"]},"institutions":[{"id":"https://openalex.org/I15059493","display_name":"\u0130zmir University of Economics","ror":"https://ror.org/04hjr4202","country_code":"TR","type":"education","lineage":["https://openalex.org/I15059493"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Serkan Ozakbas","raw_affiliation_strings":["Izmir University of Economics, Neurology Clinic, Sakarya Street, No:156, Bal\u00e7ova, \u0130zmir, TR 35330, Turkey. Electronic address: serkan.ozakbas@gmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Izmir University of Economics, Neurology Clinic, Sakarya Street, No:156, Bal\u00e7ova, \u0130zmir, TR 35330, Turkey. Electronic address: serkan.ozakbas@gmail.com","institution_ids":["https://openalex.org/I15059493"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5090065082","https://openalex.org/A5093027486","https://openalex.org/A5117063374","https://openalex.org/A5124711417","https://openalex.org/A5124734681"],"corresponding_institution_ids":["https://openalex.org/I15059493","https://openalex.org/I193615760"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":2.9718,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.84060792,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"108","issue":null,"first_page":"107044","last_page":"107044"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fingolimod","display_name":"fingolimod","score":1.0},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.953000009059906},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/secondary-progressive-multiple-sclerosis","display_name":"secondary progressive multiple sclerosis","score":0.996999979019165},{"id":"https://openalex.org/keywords/annualized-relapse-rate","display_name":"annualized relapse rate","score":0.9279999732971191},{"id":"https://openalex.org/keywords/expanded-disability-status-scale","display_name":"Expanded Disability Status Scale","score":0.9369999766349792},{"id":"https://openalex.org/keywords/no-evidence-of-disease-activity","display_name":"no evidence of disease activity","score":0.9049999713897705},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.47999998927116394},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.6830000281333923},{"id":"https://openalex.org/keywords/disability-progression","display_name":"disability progression","score":0.6240000128746033},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.6549999713897705}],"concepts":[{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.989300012588501},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9546999931335449},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.9228000044822693},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5547999739646912},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5436999797821045},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3797000050544739},{"id":"https://openalex.org/C2776291640","wikidata":"https://www.wikidata.org/wiki/Q2912517","display_name":"Value (mathematics)","level":2,"score":0.362199991941452},{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.3215999901294708},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3154999911785126},{"id":"https://openalex.org/C3020694758","wikidata":"https://www.wikidata.org/wiki/Q42417392","display_name":"Relapsing remitting","level":3,"score":0.30649998784065247},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2711000144481659},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2678999900817871},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.25600001215934753}],"mesh":[{"descriptor_ui":"D000068876","descriptor_name":"Fingolimod Hydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004185","descriptor_name":"Disability Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020528","descriptor_name":"Multiple Sclerosis, Chronic Progressive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020528","descriptor_name":"Multiple Sclerosis, Chronic Progressive","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.msard.2026.107044","doi":"https://doi.org/10.1016/j.msard.2026.107044","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.msard.2026.107044","pdf_url":null,"source":{"id":"https://openalex.org/S2764622253","display_name":"Multiple Sclerosis and Related Disorders","issn_l":"2211-0348","issn":["2211-0348","2211-0356"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis and Related Disorders","raw_type":"journal-article"},{"id":"pmid:41653645","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41653645","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple sclerosis and related disorders","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1563482990","https://openalex.org/W2104948944","https://openalex.org/W2112165124","https://openalex.org/W2776813496","https://openalex.org/W2780926505","https://openalex.org/W3016996807","https://openalex.org/W4206508748","https://openalex.org/W4224243155"],"related_works":["https://openalex.org/W4389438091","https://openalex.org/W2963106066","https://openalex.org/W2785457425","https://openalex.org/W3016996807","https://openalex.org/W2235417077","https://openalex.org/W3090528367","https://openalex.org/W2617486356","https://openalex.org/W3045065922","https://openalex.org/W4321783216","https://openalex.org/W1540044878"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2026-02-03T00:00:00"}
